Protocols

CRISPR-Cas9 genome editing is a revolutionary technology that allows rapid and precise modification of the eukaryotic genome. Developed in 2013, the technology has exploded, with over 1000 published articles using the technology. Given the simplicity and efficiency of the technology, our … Read More

Categories

Archives

About Us

The Perkins Lab is interested in how transcription factors control blood development and how mutations can lead to diseases like cancer. Our research also focuses on inherited and acquired disorders of blood cell production including myeloproliferative neoplasms and myelodysplastic syndromes.
We utilize advanced genomic techniques to investigate mechanisms of disease and translate these into potential therapies. If you’d like to find out more about us, pleasecontact us.